Neurensin-2 Inhibitors

The chemical class of Neurensin-2 Inhibitors represents an array of compounds that may modulate the expression or activity of Neurensin-2 (NRSN2), a vesicular protein primarily found in select GABAergic interneurons. The modulation of Neurensin-2 is of particular interest due to its role in emotional behavior regulation through the mediation of glutamatergic signaling. The compounds falling under this class may exhibit their inhibitory effects through various molecular mechanisms. For instance, they might interact with the serotonergic system, as seen with certain selective serotonin reuptake inhibitors (SSRIs) which have been noted to induce dynamic expression changes in Neurensin-2. Moreover, the inhibitory effects might also stem from interactions with other molecular entities like the chromatin-remodeler SMARCA3, which has been identified to repress Neurensin-2 expression thereby affecting glutamatergic signaling in interneurons.

Furthermore, Neurensin-2 Inhibitors may exert their effects by modulating the activity of receptors or signaling pathways associated with Neurensin-2 expression. Compounds that antagonize AMPA receptors or modulate glutamate and GABA receptor signaling could potentially affect Neurensin-2 expression. Additionally, the chromatin structure and transcriptional regulation surrounding the NRSN2 gene could be targeted by compounds like Histone Deacetylase Inhibitors or DNA methylation inhibitors, leading to modulated expression of Neurensin-2.